Opportunity overview
Supply of Hereditary Angioedema Branded Medicines (Cinryze® and Takhzyro®) to NHS Scotland.
Awarded to
Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.
Takeda UK Limited
2 award entriesMatched by exact name
- Contract value
- £9.5m
- Awarded
- Not supplied
- Contract signed
- 3 Apr 2025
- Status
- active
- Location
- London, UKM, W2 6BD, United Kingdom
View 2 award IDs
013177-2025-1, 018770-2025-1
Classification
- CPV33600000 — Pharmaceutical products
Lots
- The Framework Agreement is for the supply of several hereditary angioedema (HAE) branded medicines to NHS Scotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participant.Value not stated